IDEAYA Biosciences, Inc(NASDAQ:IDYA) 
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate is IDE196, a protein kinase C inhibitor that is...
Website: http://www.ideayabio.com
Founded: 2015
IPO Price: $10 (May 23, 2019)
Full Time Employees: 58
CEO: Yujiro S. Hata
Sector: Healthcare
Industry: Biotechnology
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
collaboration revenue | 6,560,000 | 10,876,000 | 207,834,000 | 3,922,000 | 8,038,000 | 3,544,000 | 7,880,000 | 4,022,000 | 29,699,000 | 5,851,000 | 11,359,000 | 2,962,000 | 8,976,000 | 8,756,000 | 7,247,000 | 10,571,000 | 8,967,000 | |||||||||||
total revenue | 6,560,000 | 10,876,000 | 207,834,000 | 3,922,000 | 8,038,000 | 3,544,000 | 7,880,000 | 4,022,000 | 29,699,000 | 5,851,000 | 11,359,000 | 10,571,000 | 8,967,000 | |||||||||||||||
yoy | NaN% | NaN% | NaN% | NaN% | -2.49% | -72.94% | -39.43% | -30.63% | ||||||||||||||||||||
qoq | -39.68% | -94.77% | NaN% | NaN% | NaN% | -51.21% | 126.81% | -55.03% | 95.92% | -86.46% | 407.59% | -48.49% | 17.89% | |||||||||||||||
operating expenses | ||||||||||||||||||||||||||||
research and development | 95,726,000 | 86,599,000 | 82,993,000 | 74,226,000 | 70,886,000 | 140,183,000 | 57,152,000 | 54,533,000 | 42,805,000 | 38,770,000 | 33,701,000 | 29,178,000 | 27,859,000 | 24,713,000 | 22,372,000 | 22,796,000 | 19,656,000 | 16,110,000 | 15,503,000 | 14,979,000 | 11,566,000 | 12,051,000 | 10,025,000 | 8,596,000 | 9,026,000 | 8,541,000 | 8,923,000 | 8,859,000 |
general and administrative | 19,378,000 | 18,847,000 | 16,389,000 | 14,580,000 | 13,503,000 | 10,955,000 | 9,741,000 | 10,394,000 | 8,212,000 | 7,069,000 | 7,863,000 | 7,075,000 | 6,300,000 | 5,752,000 | 6,667,000 | 5,554,000 | 5,923,000 | 5,221,000 | 5,186,000 | 4,828,000 | 4,816,000 | 3,800,000 | 3,938,000 | 3,994,000 | 3,452,000 | 2,778,000 | 2,700,000 | 2,376,000 |
total operating expenses | 115,104,000 | 105,446,000 | 99,382,000 | 88,806,000 | 84,389,000 | 151,138,000 | 66,893,000 | 64,927,000 | 51,017,000 | 45,839,000 | 41,564,000 | 36,253,000 | 34,159,000 | 30,465,000 | 29,039,000 | 28,350,000 | 25,579,000 | 21,331,000 | 20,689,000 | 19,807,000 | 16,382,000 | 15,851,000 | 13,963,000 | 12,590,000 | 12,478,000 | 11,319,000 | 11,623,000 | 11,235,000 |
income from operations | -108,544,000 | -94,570,000 | 108,452,000 | -88,806,000 | -84,389,000 | -144,138,000 | -66,893,000 | -64,927,000 | -51,017,000 | -41,917,000 | -33,526,000 | -32,709,000 | -26,279,000 | -26,443,000 | 660,000 | -22,499,000 | -14,220,000 | -18,369,000 | -11,713,000 | -11,051,000 | -9,135,000 | -5,280,000 | -4,996,000 | -12,590,000 | -12,478,000 | -11,319,000 | -11,623,000 | -11,235,000 |
yoy | 28.62% | -34.39% | -262.13% | 36.78% | 65.41% | 243.87% | 99.53% | 98.50% | 94.14% | 58.52% | -5179.70% | 45.38% | 84.80% | 43.95% | -105.63% | 103.59% | 55.67% | 247.90% | 134.45% | -12.22% | -26.79% | -53.35% | -57.02% | 12.06% | ||||
qoq | 14.78% | -187.20% | -222.12% | 5.23% | -41.45% | 115.48% | 3.03% | 27.27% | 21.71% | 25.03% | 2.50% | 24.47% | -0.62% | -4106.52% | -102.93% | 58.22% | -22.59% | 56.83% | 5.99% | 20.97% | 73.01% | 5.68% | -60.32% | 0.90% | 10.24% | -2.62% | 3.45% | |
operating margin % | -1654.63% | -869.53% | 52.18% | -Infinity% | -Infinity% | -Infinity% | NaN% | NaN% | NaN% | -1068.77% | -417.09% | -922.94% | -333.49% | -657.46% | 2.22% | -384.53% | -125.19% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -49.95% | -55.72% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% |
other income | 2,000 | 6,000 | ||||||||||||||||||||||||||
interest income and other income | 10,005,000 | 11,297,000 | 10,792,000 | 11,315,000 | 12,211,000 | 13,826,000 | 15,072,000 | 12,155,000 | 11,445,000 | 7,962,000 | 6,086,000 | 4,783,000 | 2,639,000 | 2,242,000 | 955,000 | 443,000 | 207,000 | 157,000 | 131,000 | 104,000 | 114,000 | 145,000 | 70,000 | 199,000 | 435,000 | |||
net income | -98,539,000 | -83,273,000 | 119,244,000 | -77,491,000 | -72,178,000 | -130,312,000 | -51,821,000 | -52,772,000 | -39,572,000 | -33,955,000 | -27,440,000 | -27,926,000 | -23,640,000 | -24,201,000 | 1,615,000 | -22,056,000 | -14,013,000 | -18,212,000 | -11,582,000 | -10,947,000 | -9,021,000 | -5,135,000 | -4,926,000 | -12,391,000 | -12,043,000 | -10,781,000 | -10,969,000 | -10,656,000 |
yoy | 36.52% | -36.10% | -330.11% | 46.84% | 82.40% | 283.78% | 88.85% | 88.97% | 67.39% | 40.30% | -1799.07% | 26.61% | 68.70% | 32.88% | -113.94% | 101.48% | 55.34% | 254.66% | 135.12% | -11.65% | -25.09% | -52.37% | -55.09% | 16.28% | ||||
qoq | 18.33% | -169.83% | -253.88% | 7.36% | -44.61% | 151.47% | -1.80% | 33.36% | 16.54% | 23.74% | -1.74% | 18.13% | -2.32% | -1598.51% | -107.32% | 57.40% | -23.06% | 57.24% | 5.80% | 21.35% | 75.68% | 4.24% | -60.25% | 2.89% | 11.71% | -1.71% | 2.94% | |
net income margin % | -1502.12% | -765.66% | 57.37% | -Infinity% | -Infinity% | -Infinity% | NaN% | NaN% | NaN% | -865.76% | -341.38% | -787.98% | -300.00% | -601.72% | 5.44% | -376.96% | -123.36% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -48.58% | -54.93% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% |
unrealized gains on marketable securities | -2,761,000 | 215,000 | 531,000 | -64,000 | 773,000 | -3,024,000 | 5,252,000 | -493,000 | -1,485,000 | 1,312,000 | 429,000 | 226,000 | ||||||||||||||||
comprehensive loss | -101,300,000 | -77,555,000 | -71,405,000 | -133,336,000 | -46,569,000 | -53,265,000 | -41,057,000 | -27,700,000 | -22,174,000 | -22,881,000 | -16,105,000 | -18,874,000 | -11,628,000 | -10,950,000 | -9,028,000 | -5,163,000 | -4,948,000 | -12,334,000 | -12,108,000 | -10,794,000 | -10,928,000 | -10,627,000 | ||||||
net loss per common share, basic and diluted | -1,110 | -880 | -820 | -1,550 | -600 | -680 | -530 | -500 | -490 | -570 | -360 | -490 | -310 | -330 | -280 | -140 | -170 | -590 | -590 | |||||||||
weighted-average common shares outstanding, basic and diluted | 88,699,754,000 | 88,472,197,000 | 88,356,335,000 | 86,188,510,000 | 77,962,730,000 | 75,108,484,000 | ||||||||||||||||||||||
comprehensive income | -7,296,250 | 119,775,000 | -19,221,250 | -27,011,000 | -9,436,000 | 1,242,000 | ||||||||||||||||||||||
net income per common share, basic | -85 | 1,350 | -360 | -460 | -220 | 40 | ||||||||||||||||||||||
weighted-average common shares outstanding, basic | 88,526,781,000 | |||||||||||||||||||||||||||
net income per common share, diluted | -85 | 1,330 | -0.36 | -0.46 | -0.22 | 0.04 | ||||||||||||||||||||||
weighted-average common shares outstanding, diluted | 89,690,878,000 | |||||||||||||||||||||||||||
weighted-average number of common shares outstanding used in computing net loss per share, basic | 59,999,449 | |||||||||||||||||||||||||||
weighted-average number of common shares outstanding used in computing net loss per share, diluted | 59,999,449 | |||||||||||||||||||||||||||
weighted-average number of common shares outstanding used in computing net loss per share, basic and diluted | 88,485,238 | 81,678,069 | 57,519,929 | 56,251,130 | 48,370,074 | 41,444,696 | 38,660,971 | 38,591,966 | 35,252,443 | 37,769,910 | 32,854,926 | 31,761,207 | 24,721,775 | 28,396,670 | 21,001,730 | 20,250,549 | ||||||||||||
unrealized losses on marketable securities | 1,466,000 | 1,131,000 | -373,000 | -825,000 | -2,092,000 | |||||||||||||||||||||||
weighted-average number of common shares outstanding used in computing net income (loss) per share, basic | 40,301,568 | |||||||||||||||||||||||||||
weighted-average number of common shares outstanding used in computing net income (loss) per share, diluted | 41,109,571 | |||||||||||||||||||||||||||
change in unrealized losses on marketable securities | -14,250 | -46,000 | -3,000 | -7,000 | ||||||||||||||||||||||||
change in unrealized gains on marketable securities | -28,000 | -22,000 | 57,000 | -65,000 | 27,250 | 41,000 | 29,000 | |||||||||||||||||||||
interest income | 536,000 | 654,000 | 573,000 | |||||||||||||||||||||||||
net income per share | -0.21 | -0.54 | -1.3 | |||||||||||||||||||||||||
weighted-average number of shares outstanding, basic and diluted | 20,158,223 | 8,218,010 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||
current assets | |||||||||||||||||||||||||||
cash and cash equivalents | 112,825,000 | 298,927,000 | 114,645,000 | 129,996,000 | 84,378,000 | 400,283,000 | 183,049,000 | 108,345,000 | 157,018,000 | 151,850,000 | 102,843,000 | 67,237,000 | 68,632,000 | 101,954,000 | 49,106,000 | 55,291,000 | 92,046,000 | 108,428,000 | 90,427,000 | 136,752,000 | 72,037,000 | 81,238,000 | 147,543,000 | 35,462,000 | 34,067,000 | 38,848,000 | 88,115,000 |
short-term marketable securities | 526,563,000 | 487,967,000 | 555,093,000 | 562,512,000 | 591,941,000 | 519,746,000 | 518,609,000 | 590,427,000 | 368,096,000 | 316,901,000 | 390,873,000 | 272,233,000 | 296,197,000 | 284,290,000 | 219,514,000 | 197,308,000 | 154,724,000 | 156,123,000 | 183,749,000 | 165,569,000 | 211,548,000 | 197,445,000 | 22,871,000 | 52,401,000 | 64,889,000 | 70,508,000 | 32,048,000 |
prepaid expenses and other current assets | 21,366,000 | 15,761,000 | 15,864,000 | 15,364,000 | 13,391,000 | 12,165,000 | 11,520,000 | 10,566,000 | 7,500,000 | 6,728,000 | 7,912,000 | 4,020,000 | 5,414,000 | 3,744,000 | 3,281,000 | 2,753,000 | 3,123,000 | 3,394,000 | 4,288,000 | 2,915,000 | 3,143,000 | 2,654,000 | 3,536,000 | 1,601,000 | 2,698,000 | 2,805,000 | 2,469,000 |
contract assets | 5,973,000 | ||||||||||||||||||||||||||
total current assets | 666,727,000 | 802,655,000 | 685,602,000 | 707,872,000 | 689,713,000 | 932,214,000 | 713,179,000 | 709,353,000 | 532,632,000 | 482,182,000 | 501,788,000 | 343,958,000 | 370,454,000 | 393,437,000 | 272,189,000 | 256,049,000 | 250,996,000 | 268,963,000 | 279,789,000 | 308,158,000 | 288,605,000 | 281,337,000 | 173,950,000 | 89,464,000 | 101,654,000 | 112,161,000 | 122,632,000 |
restricted cash | 1,015,000 | 805,000 | 805,000 | 805,000 | 805,000 | 911,000 | 911,000 | 757,000 | 757,000 | 722,000 | 722,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 | 106,000 |
long-term marketable securities | 410,297,000 | 349,960,000 | 322,131,000 | 358,665,000 | 405,832,000 | 280,128,000 | 251,071,000 | 242,636,000 | 107,492,000 | 42,394,000 | 16,377,000 | 11,740,000 | 8,317,000 | 7,691,000 | 55,171,000 | 93,628,000 | 121,293,000 | 121,217,000 | 38,254,000 | 8,080,000 | 10,158,000 | 1,545,000 | 3,040,000 | 1,526,000 | |||
property and equipment | 8,217,000 | 8,172,000 | 8,819,000 | 8,871,000 | 8,966,000 | 8,235,000 | 7,122,000 | 6,909,000 | 6,164,000 | 6,192,000 | 6,829,000 | 6,716,000 | 6,509,000 | 6,679,000 | 7,163,000 | 5,274,000 | 4,763,000 | 4,707,000 | 4,898,000 | 4,755,000 | 4,271,000 | 4,095,000 | 4,289,000 | 4,337,000 | 4,642,000 | 4,767,000 | 5,050,000 |
right-of-use assets | 23,068,000 | 23,544,000 | 23,913,000 | 24,428,000 | 18,775,000 | 18,385,000 | 1,305,000 | 1,780,000 | 2,246,000 | 1,347,000 | 1,733,000 | 2,112,000 | 2,484,000 | 2,848,000 | 3,204,000 | 3,554,000 | 3,898,000 | 4,234,000 | 4,563,000 | 4,887,000 | 5,205,000 | 5,515,000 | 4,594,000 | 4,828,000 | 5,057,000 | 5,279,000 | 5,545,000 |
total assets | 1,109,324,000 | 1,185,136,000 | 1,041,270,000 | 1,100,641,000 | 1,124,091,000 | 1,239,873,000 | 973,663,000 | 961,527,000 | 649,316,000 | 532,942,000 | 527,557,000 | 364,746,000 | 387,969,000 | 410,907,000 | 338,007,000 | 358,867,000 | 381,347,000 | 399,444,000 | 328,401,000 | 326,097,000 | 298,269,000 | 301,384,000 | 184,510,000 | 101,791,000 | 113,001,000 | 122,331,000 | 133,358,000 |
liabilities and stockholders’ equity | |||||||||||||||||||||||||||
current liabilities | |||||||||||||||||||||||||||
accounts payable | 17,584,000 | 18,433,000 | 17,270,000 | 17,631,000 | 15,421,000 | 12,567,000 | 15,886,000 | 6,290,000 | 6,598,000 | 5,169,000 | 5,868,000 | 4,376,000 | 4,280,000 | 3,645,000 | 4,227,000 | 3,364,000 | 2,100,000 | 2,152,000 | 2,108,000 | 1,281,000 | 953,000 | 1,405,000 | 952,000 | 684,000 | 709,000 | 763,000 | 1,080,000 |
accrued liabilities | 40,892,000 | 45,258,000 | 37,750,000 | 32,907,000 | 30,352,000 | 28,092,000 | 24,250,000 | 17,519,000 | 18,756,000 | 16,188,000 | 14,690,000 | 17,274,000 | 16,999,000 | 16,988,000 | 16,230,000 | 12,628,000 | 12,320,000 | 11,892,000 | 9,910,000 | 7,756,000 | 8,516,000 | 6,390,000 | 5,223,000 | 5,429,000 | 5,023,000 | 3,992,000 | 4,077,000 |
operating lease liabilities, current | 339,000 | 328,000 | 318,000 | 308,000 | 298,000 | 606,000 | 1,151,000 | 1,747,000 | 1,871,000 | 1,699,000 | 1,540,000 | ||||||||||||||||
total current liabilities | 58,815,000 | 64,509,000 | 55,338,000 | 50,846,000 | 46,071,000 | 40,659,000 | 40,742,000 | 24,960,000 | 27,101,000 | 24,893,000 | 25,337,000 | 29,820,000 | 31,718,000 | 32,727,000 | 58,089,000 | 56,957,000 | 45,159,000 | 38,637,000 | 35,771,000 | 36,129,000 | 38,640,000 | 54,173,000 | 7,426,000 | 7,346,000 | 6,940,000 | 5,947,000 | 6,473,000 |
long-term operating lease liabilities | 27,575,000 | 26,917,000 | 26,279,000 | 25,660,000 | 18,873,000 | 18,796,000 | 1,263,000 | 1,256,000 | 1,125,000 | 611,000 | 1,116,000 | 1,611,000 | 2,097,000 | 2,572,000 | 3,031,000 | 3,482,000 | 5,183,000 | ||||||||||
total liabilities | 86,390,000 | 93,102,000 | 81,617,000 | 76,506,000 | 64,944,000 | 59,455,000 | 42,005,000 | 26,216,000 | 28,226,000 | 24,893,000 | 25,948,000 | 30,936,000 | 38,514,000 | 42,138,000 | 68,686,000 | 70,200,000 | 79,833,000 | 81,815,000 | 88,141,000 | 92,971,000 | 99,995,000 | 105,955,000 | 12,452,000 | 12,688,000 | 12,601,000 | 11,925,000 | 12,750,000 |
commitments and contingencies | |||||||||||||||||||||||||||
stockholders’ equity | |||||||||||||||||||||||||||
preferred stock, 0.0001 par value... | |||||||||||||||||||||||||||
common stock, 0.0001 par value... | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 8,000 | 7,000 | 7,000 | 6,000 | 6,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 2,000 | 2,000 | 2,000 | 2,000 |
additional paid-in capital | 1,757,197,000 | 1,743,239,000 | 1,730,633,000 | 1,717,560,000 | 1,681,167,000 | 1,669,102,000 | 1,373,774,000 | 1,324,163,000 | 968,885,000 | 823,202,000 | 789,751,000 | 594,253,000 | 587,724,000 | 583,968,000 | 485,763,000 | 482,228,000 | 478,970,000 | 476,211,000 | 387,215,000 | 369,130,000 | 325,250,000 | 317,242,000 | 288,923,000 | 193,635,000 | 192,824,000 | 192,036,000 | 191,310,000 |
accumulated other comprehensive income | 2,267,000 | 2,052,000 | 1,521,000 | 1,585,000 | 812,000 | 3,836,000 | -1,416,000 | -923,000 | 562,000 | -712,000 | -50,000 | -4,000 | 7,000 | 35,000 | 57,000 | 65,000 | 78,000 | 37,000 | |||||||||
accumulated deficit | -736,539,000 | -653,266,000 | -772,510,000 | -695,019,000 | -622,841,000 | -492,529,000 | -440,708,000 | -387,936,000 | -348,364,000 | -314,409,000 | -286,969,000 | -259,043,000 | -235,403,000 | -211,202,000 | -212,817,000 | -190,761,000 | -176,748,000 | -158,536,000 | -146,954,000 | -136,007,000 | -126,986,000 | -121,851,000 | -116,925,000 | -104,534,000 | -92,491,000 | -81,710,000 | -70,741,000 |
total stockholders’ equity | 1,022,934,000 | 1,092,034,000 | 959,653,000 | 1,024,135,000 | 1,059,147,000 | 1,180,418,000 | 931,658,000 | 935,311,000 | 621,090,000 | 508,049,000 | 501,609,000 | 333,810,000 | 349,455,000 | 368,769,000 | 269,321,000 | 288,667,000 | 301,514,000 | 317,629,000 | 240,260,000 | 233,126,000 | 198,274,000 | 195,429,000 | 172,058,000 | 89,103,000 | 100,400,000 | 110,406,000 | 120,608,000 |
total liabilities and stockholders’ equity | 1,109,324,000 | 1,185,136,000 | 1,041,270,000 | 1,100,641,000 | 1,124,091,000 | 1,239,873,000 | 973,663,000 | 961,527,000 | 649,316,000 | 532,942,000 | 527,557,000 | 364,746,000 | 387,969,000 | 410,907,000 | 338,007,000 | 358,867,000 | 381,347,000 | 399,444,000 | 328,401,000 | 326,097,000 | 298,269,000 | 301,384,000 | 184,510,000 | 101,791,000 | |||
contract liabilities, current | 490,000 | ||||||||||||||||||||||||||
long-term contract liabilities | 1,676,000 | ||||||||||||||||||||||||||
accounts receivable | 3,000 | 20,000 | 1,000 | 15,000 | 18,000 | 6,703,000 | 160,000 | 468,000 | 211,000 | 3,449,000 | 288,000 | 697,000 | 1,103,000 | 1,018,000 | 1,325,000 | 2,922,000 | 1,877,000 | ||||||||||
other non-current assets | 75,000 | 92,000 | 25,000 | 105,000 | 108,000 | 114,000 | 99,000 | 146,000 | 174,000 | 256,000 | 291,000 | 217,000 | 791,000 | 111,000 | 82,000 | 173,000 | 26,000 | 16,000 | 16,000 | 18,000 | 25,000 | ||||||
contract liability | 1,439,000 | 2,818,000 | 6,255,000 | 8,568,000 | 10,267,000 | 35,849,000 | 39,224,000 | 29,040,000 | 22,935,000 | 22,132,000 | 25,508,000 | 27,613,000 | 44,847,000 | ||||||||||||||
long-term contract liability | 5,185,000 | 7,314,000 | 8,025,000 | 10,212,000 | 31,192,000 | 39,248,000 | 48,008,000 | 52,063,000 | 56,160,000 | 46,186,000 | |||||||||||||||||
operating lease liabilities - current | 2,097,000 | 1,961,000 | 1,915,000 | 1,827,000 | 1,783,000 | 1,741,000 | |||||||||||||||||||||
accumulated other comprehensive loss | -750,000 | -1,179,000 | -1,405,000 | -2,871,000 | -4,002,000 | -3,629,000 | -2,804,000 | ||||||||||||||||||||
other current liabilities | 3,000 | 6,000 | 18,000 | 29,000 | 45,000 | 57,000 | 63,000 | 76,000 | 89,000 | ||||||||||||||||||
other non-current liabilities | 6,000 | 6,000 | 6,000 | 12,000 | 12,000 | 16,000 | 21,000 | 34,000 | 52,000 | 60,000 | |||||||||||||||||
lease liabilities | 1,658,000 | 1,618,000 | 1,578,000 | 1,502,000 | 1,206,000 | 1,176,000 | 1,145,000 | 1,116,000 | 1,227,000 | ||||||||||||||||||
long-term lease liabilities | 3,924,000 | 4,356,000 | 4,773,000 | 5,584,000 | 5,010,000 | 5,321,000 | 5,627,000 | 5,926,000 | 6,217,000 | ||||||||||||||||||
deferred offering costs | |||||||||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||
deferred rent | |||||||||||||||||||||||||||
series a redeemable convertible preferred stock, 0.0001 par value... | |||||||||||||||||||||||||||
series b redeemable convertible preferred stock, 0.0001 par value... | |||||||||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders’ equity | 113,001,000 | 122,331,000 | 133,358,000 | ||||||||||||||||||||||||
stockholder’s equity |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||||||||||
net loss | -83,273,000 | 119,244,000 | -77,491,000 | -72,178,000 | -130,312,000 | -51,821,000 | -52,772,000 | -39,572,000 | -33,955,000 | -27,440,000 | -27,926,000 | -23,640,000 | -24,201,000 | 1,615,000 | -22,056,000 | -14,013,000 | -18,212,000 | -11,582,000 | -10,947,000 | -9,021,000 | -5,135,000 | -4,926,000 | -12,391,000 | -12,043,000 | -10,781,000 | -10,969,000 |
adjustments to reconcile net loss to net cash from operating activities | ||||||||||||||||||||||||||
depreciation and amortization | 721,000 | 661,000 | 718,000 | 600,000 | 572,000 | 577,000 | 622,000 | 616,000 | 629,000 | 640,000 | 619,000 | 588,000 | 558,000 | 569,000 | 510,000 | 464,000 | 448,000 | 451,000 | 444,000 | 382,000 | 361,000 | 347,000 | 337,000 | 336,000 | 330,000 | 324,000 |
net amortization of premiums on marketable securities | -4,916,000 | -5,363,000 | -6,640,000 | -6,314,000 | -3,876,000 | -3,566,000 | -2,554,000 | -1,557,000 | -1,127,000 | -86,000 | 169,000 | 349,000 | 469,000 | 466,000 | 445,000 | 454,000 | ||||||||||
stock-based compensation | 11,793,000 | 12,217,000 | 11,868,000 | 10,237,000 | 9,485,000 | 9,215,000 | 9,734,000 | 6,312,000 | 4,798,000 | 5,301,000 | 4,731,000 | 3,659,000 | 2,975,000 | 3,005,000 | 3,044,000 | 2,605,000 | 2,064,000 | 2,197,000 | 2,058,000 | 1,918,000 | 1,046,000 | 981,000 | 824,000 | 758,000 | 719,000 | 518,000 |
amortization of right of use assets | ||||||||||||||||||||||||||
changes in assets and liabilities | ||||||||||||||||||||||||||
accounts receivable | 17,000 | -19,000 | 14,000 | 3,000 | 6,685,000 | -6,543,000 | 308,000 | -257,000 | 3,238,000 | -3,161,000 | 409,000 | 406,000 | -85,000 | 307,000 | 1,597,000 | -1,045,000 | ||||||||||
prepaid expenses and other assets | -5,562,000 | 192,000 | -500,000 | -1,970,000 | -1,736,000 | -934,000 | -371,000 | -3,133,000 | -724,000 | 1,187,000 | -3,881,000 | 1,373,000 | -1,627,000 | -441,000 | -451,000 | 400,000 | 206,000 | 1,324,000 | -1,918,000 | 199,000 | -429,000 | 767,000 | -1,945,000 | 1,097,000 | 108,000 | -328,000 |
accounts payable | -858,000 | 1,191,000 | -364,000 | 2,728,000 | 2,976,000 | -3,939,000 | 9,696,000 | -453,000 | 1,745,000 | -699,000 | 1,601,000 | -12,000 | 397,000 | -449,000 | 1,053,000 | 863,000 | -7,000 | 377,000 | 536,000 | 260,000 | -459,000 | 493,000 | 227,000 | -36,000 | -42,000 | 36,000 |
accrued and other liabilities | -4,799,000 | 7,508,000 | 4,843,000 | 2,875,000 | 2,274,000 | 2,895,000 | 6,898,000 | -1,273,000 | 2,481,000 | 2,414,000 | -2,841,000 | -419,000 | 323,000 | 1,150,000 | 2,959,000 | 140,000 | 476,000 | 2,012,000 | 2,339,000 | -615,000 | 1,806,000 | 1,437,000 | -635,000 | 384,000 | 1,030,000 | 55,000 |
contract assets and liabilities | ||||||||||||||||||||||||||
lease liabilities | 669,000 | 648,000 | 629,000 | 611,000 | -86,000 | -280,000 | -538,000 | -465,000 | -487,000 | -475,000 | -459,000 | -451,000 | -442,000 | -431,000 | -417,000 | -409,000 | -401,000 | -392,000 | -377,000 | -372,000 | -363,000 | 870,000 | -281,000 | -275,000 | -270,000 | -402,000 |
net cash from operating activities | -90,496,000 | 142,214,000 | -62,474,000 | -60,342,000 | -121,655,000 | -49,234,000 | -32,882,000 | -43,813,000 | -23,748,000 | -30,174,000 | -33,460,000 | -27,842,000 | -23,370,000 | -24,166,000 | -19,992,000 | -19,647,000 | -16,657,000 | -12,468,000 | -12,930,000 | -13,724,000 | -11,596,000 | 90,210,000 | -13,606,000 | -9,545,000 | -8,706,000 | -10,550,000 |
capital expenditures | 100,000 | -70,000 | -660,000 | -676,000 | -901,000 | 776,000 | -1,111,000 | -1,142,000 | -838,000 | -603,000 | -1,030,000 | 703,000 | 0 | -1,101,000 | -1,470,000 | 149,000 | -699,000 | -650,000 | -583,000 | -620,000 | 180,000 | -337,000 | 220,000 | -216,000 | -113,000 | |
free cash flows | -90,396,000 | 142,144,000 | -63,134,000 | -61,018,000 | -122,556,000 | -48,458,000 | -33,993,000 | -44,955,000 | -24,586,000 | -30,777,000 | -34,490,000 | -27,139,000 | -23,370,000 | -25,267,000 | -21,462,000 | -19,498,000 | -17,356,000 | -13,118,000 | -13,513,000 | -14,344,000 | -11,416,000 | 89,873,000 | -13,386,000 | -8,922,000 | -10,663,000 | |
cash flows from investing activities | ||||||||||||||||||||||||||
purchases of property and equipment | -333,000 | -42,000 | -663,000 | -1,330,000 | -1,102,000 | -457,000 | -973,000 | -1,325,000 | -838,000 | -603,000 | -884,000 | -43,000 | 0 | -1,101,000 | -1,941,000 | -401,000 | -605,000 | -458,000 | -578,000 | -1,003,000 | -179,000 | -245,000 | -216,000 | -82,000 | ||
purchases of marketable securities | -236,138,000 | -138,991,000 | -127,553,000 | -105,207,000 | -337,041,000 | -213,724,000 | -164,763,000 | -475,781,000 | -221,605,000 | -81,832,000 | -220,247,000 | -72,296,000 | -65,501,000 | -88,085,000 | -37,922,000 | -64,300,000 | -32,568,000 | -149,382,000 | -94,308,000 | -38,738,000 | -27,902,000 | -188,166,000 | -14,993,000 | -11,253,000 | -1,887,000 | -47,659,000 |
maturities of marketable securities | 138,945,000 | 180,800,000 | 174,134,000 | 186,354,000 | 141,034,000 | 194,145,000 | 234,293,000 | 123,135,000 | 110,500,000 | 133,782,000 | 99,750,000 | 95,860,000 | 55,225,000 | 70,503,000 | 53,179,000 | 46,940,000 | 32,760,000 | 93,533,000 | 41,487,000 | 76,176,000 | 23,527,000 | 4,828,000 | 46,050,000 | 22,159,000 | 5,990,000 | 49,444,000 |
net cash from investing activities | -97,526,000 | 41,767,000 | 45,918,000 | 79,817,000 | -197,109,000 | -20,036,000 | 68,557,000 | -353,971,000 | -111,943,000 | 51,347,000 | -121,381,000 | 23,521,000 | -10,276,000 | -18,683,000 | 13,316,000 | -17,761,000 | -413,000 | -56,307,000 | -49,381,000 | 36,435,000 | -4,554,000 | -183,583,000 | 30,988,000 | 10,906,000 | 3,887,000 | -38,441,000 |
cash flows from financing activities | ||||||||||||||||||||||||||
proceeds from issuance of common stock in public offering, net of issuance costs | ||||||||||||||||||||||||||
proceeds from issuances of pre-funded warrants | ||||||||||||||||||||||||||
proceeds from issuance of common stock related to at-the-market offering program, net of issuance costs | -46,000 | -83,000 | -25,000 | 25,009,000 | -65,000 | -27,000 | 36,321,000 | 343,650,000 | -156,000 | 26,228,000 | -34,000 | 2,560,000 | -138,000 | 9,070,000 | -66,000 | -9,000 | -23,000 | -22,000 | 15,416,000 | 41,892,000 | ||||||
proceeds from exercise of common stock options | 1,503,000 | 384,000 | 410,000 | 1,134,000 | 2,500,000 | 2,441,000 | 2,081,000 | 5,461,000 | 1,855,000 | 34,000 | 38,000 | 184,000 | ||||||||||||||
proceeds from espp purchases | ||||||||||||||||||||||||||
net cash from financing activities | 2,130,000 | 301,000 | 1,205,000 | 26,143,000 | 2,753,000 | 286,504,000 | 39,183,000 | 349,111,000 | 140,894,000 | 27,834,000 | 191,063,000 | 2,926,000 | 324,000 | 95,697,000 | 491,000 | 653,000 | 688,000 | 86,776,000 | 15,986,000 | 42,004,000 | 6,949,000 | 27,068,000 | 94,699,000 | 34,000 | 38,000 | -276,000 |
net increase in cash, cash equivalents and restricted cash | -185,892,000 | 184,282,000 | -15,351,000 | 45,618,000 | -316,011,000 | 217,234,000 | 5,203,000 | 49,007,000 | -33,322,000 | 52,848,000 | -16,382,000 | 18,001,000 | -46,325,000 | 64,715,000 | -9,201,000 | -66,305,000 | 112,081,000 | 1,395,000 | -4,781,000 | -49,267,000 | ||||||
cash, cash equivalents and restricted cash | -185,892,000 | 184,282,000 | -15,351,000 | 130,801,000 | -316,011,000 | 217,234,000 | 74,858,000 | 109,102,000 | 5,203,000 | 49,007,000 | 36,222,000 | 67,343,000 | -33,322,000 | 52,848,000 | -6,185,000 | 55,397,000 | -16,382,000 | 18,001,000 | -46,325,000 | 136,858,000 | -9,201,000 | -66,305,000 | 112,081,000 | 35,568,000 | -4,781,000 | -49,267,000 |
cash, cash equivalents and restricted cash, at beginning of period | 0 | 0 | 0 | 85,183,000 | 0 | 0 | 0 | 157,775,000 | 0 | 0 | 0 | 68,738,000 | 0 | 0 | 0 | 92,152,000 | 0 | 0 | 0 | 72,143,000 | 0 | 0 | 0 | 34,173,000 | 0 | 0 |
cash, cash equivalents and restricted cash, at end of period | -185,892,000 | 184,282,000 | -15,351,000 | 130,801,000 | -316,011,000 | 217,234,000 | 74,858,000 | 109,102,000 | 5,203,000 | 49,007,000 | 36,222,000 | 67,343,000 | -33,322,000 | 52,848,000 | -6,185,000 | 55,397,000 | -16,382,000 | 18,001,000 | -46,325,000 | 136,858,000 | -9,201,000 | -66,305,000 | 112,081,000 | 35,568,000 | -4,781,000 | -49,267,000 |
reconciliation of cash, cash equivalents and restricted cash | ||||||||||||||||||||||||||
cash and cash equivalents | -186,102,000 | 184,282,000 | -15,351,000 | 129,996,000 | -315,905,000 | 217,234,000 | 74,704,000 | 108,345,000 | 5,168,000 | 49,007,000 | 35,606,000 | 67,237,000 | -33,322,000 | 52,848,000 | -6,185,000 | 55,291,000 | -16,382,000 | 18,001,000 | -46,325,000 | 136,752,000 | -9,201,000 | -66,305,000 | 112,081,000 | 35,462,000 | -4,781,000 | -49,267,000 |
restricted cash | 210,000 | 0 | 0 | 805,000 | -106,000 | 0 | 154,000 | 757,000 | 35,000 | 0 | 616,000 | 106,000 | 0 | 0 | 0 | 106,000 | 0 | 0 | 0 | 106,000 | 0 | 0 | 0 | 106,000 | 0 | 0 |
supplemental disclosure of cash flow information: | ||||||||||||||||||||||||||
cash paid for interest | 0 | 3,000 | 10,000 | 12,000 | 32,000 | 11,000 | 13,000 | 13,000 | 14,000 | 14,000 | 16,000 | 16,000 | 16,000 | 18,000 | 18,000 | 19,000 | 20,000 | 20,000 | 21,000 | 21,000 | 22,000 | 45,000 | ||||
supplemental non-cash investing and financing activities: | ||||||||||||||||||||||||||
right-of-use asset obtained in exchange for a new operating lease liability | 0 | 0 | 0 | 6,186,000 | 461,000 | |||||||||||||||||||||
purchases of property and equipment in accounts payable and accrued liabilities | 433,000 | -28,000 | 3,000 | 654,000 | 201,000 | 1,233,000 | -138,000 | 183,000 | -146,000 | 746,000 | 471,000 | 550,000 | -94,000 | -192,000 | -5,000 | 383,000 | 359,000 | -92,000 | 220,000 | 33,000 | -31,000 | |||||
unpaid offering costs | 8,000 | -316,000 | 295,000 | 56,000 | -457,000 | 111,000 | 60,000 | |||||||||||||||||||
net accretion of discounts on marketable securities | -1,982,000 | -2,692,000 | -3,778,000 | |||||||||||||||||||||||
amortization of right-of-use assets | 369,000 | 515,000 | 533,000 | 435,000 | 475,000 | 466,000 | 386,000 | 379,000 | 372,000 | 356,000 | ||||||||||||||||
contract liabilities | -1,439,000 | -1,379,000 | -3,437,000 | -7,498,000 | -3,828,000 | -26,293,000 | -5,562,000 | -10,796,000 | -1,951,000 | -7,957,000 | -7,431,000 | -6,202,000 | -7,260,000 | |||||||||||||
proceeds from issuance of common stock upon public offering, net of issuance costs | -249,000 | 6,789,000 | ||||||||||||||||||||||||
proceeds from issuance of pre-funded warrants to purchase common stock, net of issuance costs | 0 | |||||||||||||||||||||||||
proceeds from espp purchase | 0 | 0 | 0 | -349,000 | 0 | 0 | ||||||||||||||||||||
unpaid at-the-market offering program costs | -3,000 | 0 | ||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -48,673,000 | -1,395,000 | ||||||||||||||||||||||||
accrued atm costs | 145,000 | |||||||||||||||||||||||||
sales of marketable securities | 0 | 0 | 0 | -40,144,000 | ||||||||||||||||||||||
proceeds from exercise of common stock options, net of repurchases | 366,000 | 517,000 | 496,000 | -227,000 | 662,000 | 341,000 | 808,000 | 243,000 | 112,000 | 173,000 | 291,000 | |||||||||||||||
cash paid for income taxes | 0 | 0 | 0 | 0 | 0 | 1,000 | 0 | 0 | ||||||||||||||||||
vesting of early exercised options and restricted stock | 1,000 | 2,000 | 3,000 | 18,000 | 12,000 | 13,000 | 15,000 | 16,000 | 26,000 | 17,000 | ||||||||||||||||
loss on sale of property and equipment | 0 | 0 | 0 | 2,000 | 0 | 11,000 | ||||||||||||||||||||
realized gain on marketable securities | 0 | |||||||||||||||||||||||||
right-of-use assets | 344,000 | 336,000 | 329,000 | 324,000 | 318,000 | 311,000 | -921,000 | 233,000 | 229,000 | 223,000 | 266,000 | |||||||||||||||
proceeds from issuance of common stock in private placement, net of issuance costs | 0 | |||||||||||||||||||||||||
right-of-use asset obtained in exchange for new operating lease liability | ||||||||||||||||||||||||||
net incresae (decrease) in cash, cash equivalents and restricted cash | -36,755,000 | |||||||||||||||||||||||||
conversion of redeemable convertible preferred stock into common stock | 0 | 0 | ||||||||||||||||||||||||
issuance of series b redeemable convertible preferred stock pursuant to license agreement | ||||||||||||||||||||||||||
change in fair value of redeemable convertible preferred stock liability | ||||||||||||||||||||||||||
landlord contributions for leasehold improvements | ||||||||||||||||||||||||||
gain on sale of marketable securities | ||||||||||||||||||||||||||
deferred rent | ||||||||||||||||||||||||||
proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | ||||||||||||||||||||||||||
payments of deferred offering costs | ||||||||||||||||||||||||||
unpaid deferred offering costs | ||||||||||||||||||||||||||
extinguishment of redeemable convertible preferred stock liability | ||||||||||||||||||||||||||
net amortization of premiums and discounts on marketable securities | 129,000 | 26,000 | 5,000 | -61,000 | ||||||||||||||||||||||
gain on sales of marketable securities | -2,000 | 0 | ||||||||||||||||||||||||
proceeds from issuance of common stock in initial public offering, net of issuance costs | 0 | |||||||||||||||||||||||||
leasehold improvements acquired through tenant improvement allowance | ||||||||||||||||||||||||||
proceeds from issuance of initial public offering, net of issuance costs |